Jpmorgan Chase & CO Madrigal Pharmaceuticals, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 70,778 shares of MDGL stock, worth $21.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

70,778

Previous 52,656 34.42%

Holding current value

$21.8 Million

Previous $14.8 Million 1.82%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$212.22 - $292.96 $3.85 Million - $5.31 Million	18,122 Added 34.42%	70,778 $15 Million
Q2 2024 Aug 12, 2024	SELL	$193.33 - $291.99 $531,270 - $802,388	-2,748 Reduced 4.96%	52,656 $14.8 Million
Q1 2024 May 10, 2024	SELL	$171.37 - $283.23 $669,885 - $1.11 Million	-3,909 Reduced 6.59%	55,404 $14.8 Million
Q4 2023 Feb 12, 2024	SELL	$120.4 - $237.13 $4.71 Million - $9.28 Million	-39,144 Reduced 39.76%	59,313 $13.7 Million
Q3 2023 Nov 14, 2023	BUY	$146.04 - $225.78 $1.48 Million - $2.3 Million	10,166 Added 11.51%	98,457 $14.4 Million
Q2 2023 Aug 11, 2023	BUY	$203.88 - $312.0 $7.11 Million - $10.9 Million	34,849 Added 65.21%	88,291 $20.4 Million
Q1 2023 May 18, 2023	BUY	$231.06 - $307.08 $3.63 Million - $4.83 Million	15,716 Added 41.66%	53,442 $12.9 Million
Q1 2023 May 11, 2023	SELL	$231.06 - $307.08 $3.86 Million - $5.13 Million	-16,700 Reduced 30.68%	37,726 $9.14 Million
Q4 2022 Feb 13, 2023	BUY	$58.39 - $296.54 $1.06 Million - $5.37 Million	18,094 Added 49.8%	54,426 $15.8 Million
Q3 2022 Nov 14, 2022	SELL	$60.57 - $79.51 $209,996 - $275,661	-3,467 Reduced 8.71%	36,332 $2.36 Million
Q2 2022 Aug 11, 2022	BUY	$58.04 - $100.2 $239,415 - $413,325	4,125 Added 11.56%	39,799 $2.85 Million
Q1 2022 May 11, 2022	BUY	$55.89 - $101.89 $56,840 - $103,622	1,017 Added 2.93%	35,674 $3.5 Million
Q4 2021 Feb 10, 2022	SELL	$72.34 - $95.09 $90,497 - $118,957	-1,251 Reduced 3.48%	34,657 $2.94 Million
Q3 2021 Nov 12, 2021	BUY	$78.35 - $105.02 $2.81 Million - $3.77 Million	35,908 New	35,908 $2.87 Million

Others Institutions Holding MDGL

# of Institutions

297

Shares Held

22M

Call Options Held

819K

Put Options Held

640K

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.28B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Madrigal Pharmaceuticals, Inc. Transaction History